| 8/17/2009 | CV | Wyeth calls $22.66 million outstanding floating-rate convertibles
|
| 7/15/2009 | CV | Wyeth completes put of 97.1% of floating-rate convertible debentures
|
| 4/23/2009 | CV | Wyeth calls its $2 convertible preferred stock for $60.08 each; redemption date July 15
|
| 1/26/2009 | CV | Market Commentary: Convertibles little changed: Wyeth steady on Pfizer deal; Amgen active ahead of earnings; AMD gains
|
| 1/23/2009 | CV | Market Commentary: Convertibles bounce around; selling hits Nabors, Transocean, AMD; Cubist up on earnings; Wyeth up
|
| 11/7/2008 | CV | Market Commentary: GM, Ford weaker after reported losses, cash burn; Sprint Nextel extends gains; Wyeth firm
|
| 10/27/2008 | CV | Market Commentary: Convertibles mixed; Wyeth firmer; Nabors slightly better; Peabody lower, holds up better than stock
|
| 7/30/2008 | CV | Market Commentary: PSS retreats, Affiliated Managers quiet on trading start; Wyeth finds support; Penn Virginia rallies with oil
|
| 7/2/2008 | CV | Market Commentary: Smithfield Foods jumps to 103 on debut; GM, Ford slide; Coal names drop with stocks; Amgen adds
|
| 4/21/2008 | CV | Market Commentary: National City soars on financing; financials active, mixed as Bank of America reports; CIT raises $1 billion
|
| 3/25/2008 | CV | Market Commentary: Wyeth, Medtronic, Hologic trade; Bank of America lower, but Countrywide higher; MGIC prices
|
| 12/19/2007 | CVIG | Moody's rates Wyeth loans A3
|
| 9/28/2007 | CVIG | Moody's confirms Wyeth
|
| 8/10/2007 | CV | Market Commentary: Schering-Plough makes debut; Countrywide battered by misunderstanding; market has 'choppy' Friday
|
| 7/25/2007 | CV | S&P: Wyeth unaffected
|
| 6/21/2007 | CV | S&P ups Wyeth
|
| 6/4/2007 | CV | Moody's could upgrade Wyeth
|
| 5/7/2007 | CV | Market Commentary: Armor climbs on BAE buyout; Yahoo! fades with merger hopes; Gold Reserve, Chemed launch deals
|
| 3/22/2007 | CV | S&P: Wyeth on positive watch, rates notes A
|
| 3/22/2007 | CV | Moody's rates Wyeth note A3
|
| 3/22/2007 | CV | Fitch rates Wyeth note A-
|
| 2/13/2007 | CV | Market Commentary: Anixter, Illumina soar on debuts; Wyeth gains on report; Waste Connections up on results; IVG prices
|
| 12/13/2006 | CV | Moody's upgrades Wyeth to A3
|
| 11/1/2006 | BTCV | Moody's may upgrade Wyeth
|
| 10/16/2006 | CV | Market Commentary: Open Solutions soars on buyout; Bausch and Lomb, Wyeth slip on rate fears; SanDisk gains on outlook
|
| 10/13/2006 | CV | Floating-rate convertibles still attractive despite peaking interest rates, says J Giordano's Berkman
|
| 9/29/2006 | CV | Market Commentary: Brandywine lackluster on debut; Amkor reactions mixed to revised offer; Ford gains slightly
|
| 6/26/2006 | CV | Market Commentary: Intel, Amgen under pressure; Inco rises; Chesapeake launches mandatories offering
|
| 5/3/2006 | BTCV | S&P ups Wyeth outlook to stable
|
| 3/3/2006 | CV | Market Commentary: Intel holds up on hedged basis despite stock slide; Citigroup says convertible arbitrage paid off in February
|
| 1/13/2006 | CV | Market Commentary: Tyco moves lower on lower guidance, break-up plan; Lucent mixed; Wyeth up
|
| 1/3/2006 | CV | Market Commentary: Wyeth convertibles up on pact; Cephalon adds; Mercury Interactive mostly flat
|
| 12/23/2005 | CV | Market Commentary: Albertson's trades lower in active trade; Wyeth, Omnicare gain; GM sees light buying
|
| 11/9/2005 | BTCV | Moody's rates Wyeth notes Baa1
|
| 11/9/2005 | BTCV | S&P rates Wyeth notes A
|
| 11/9/2005 | BTCV | Fitch rates Wyeth notes A-
|
| 10/21/2005 | CV | Market Commentary: Wyeth holds up; Ford drops, but GM bonds move higher; Schlumberger off
|
| 7/21/2005 | BTCV | New Issue: Goldman Sachs prices $100 million 6.25% notes mandatorily exchangeable for Wyeth
|
| 7/20/2005 | CV | Market Commentary: Amgen rises in mixed convertibles trading as earnings reports roil GM, Kodak, boost Wyeth
|
| 6/28/2005 | CV | Market Commentary: Lonza issue emerges; Walter better as takeover anxiety eases; Interpublic holders to get windfall payment
|
| 4/15/2005 | CV | Market Commentary: GM, Ford selling accelerates; El Paso, Calpine, NRG plunge; Ivax, Teva lose; Lucent, Tyco unwound
|
| 2/8/2005 | CV | Moody's affirms Wyeth
|
| 1/31/2005 | CV | Fitch affirms Wyeth
|
| 1/14/2005 | CV | Market Commentary: CNet gains 4 points; Collegiate Pacific higher; UnumProvident up; Wyeth rises, Schering drops
|
| 10/13/2004 | CV | Market Commentary: Delta convertibles rise sharply; Amkor buyers heartened; Lucent edges up, Apex easier
|
| 9/24/2004 | CV | Market Commentary: Calpine new issue trade seen awkward; Dobson off on buy; PMA Capital exchange seen
|
| 9/14/2004 | CV | Market Commentary: Allied Waste issues dumped; Interpublic mandatory eyed; Mercury rises ahead of Oracle
|
| 6/16/2004 | CV | Market Commentary: Advanced Medical prices with wide coupon; Kellwood seen offered at 100.5; Delta plunges; JetBlue warns
|
| 6/9/2004 | CV | New Issue: Citigroup prices $39.8 million 6% Elks exchangeable for Wyeth
|
| 5/26/2004 | CV | S&P: Wyeth unaffected
|
| 5/25/2004 | CV | Market Commentary: Digital River, CSG deals emerge; Wild Oats at bat; Genworth edges up; Wyeth sinks; Calpine spikes
|
| 5/18/2004 | CV | S&P: Wyeth unaffected
|
| 5/18/2004 | CV | Market Commentary: Tower prices wide of revised talk, jumps to 105.5 area; TXU climbs on new plan; Wyeth off on verdict
|
| 4/8/2004 | CV | New Issue: Goldman Sachs $6 million 0.25% notes exchangeable for Wyeth yield 0.25%, up 22%
|
| 3/3/2004 | CV | S&P: Wyeth unaffected
|
| 2/2/2004 | CV | S&P: Wyeth unaffected by subpoena
|
| 1/29/2004 | CV | Market Commentary: Wyeth, Sallie Mae, Lockheed floaters see demand; hedgies hurt by premium contractions
|
| 1/16/2004 | CV | Market Commentary: Juniper zooms 30-plus points on positive earnings; several techs, telecoms join the party
|
| 12/16/2003 | CV | Market Commentary: Four deals to price after the close Tuesday; Mentor adds $125 million overnighter
|
| 12/12/2003 | CV | Market Commentary: A dozen new deals this week put $4.64 billion into market; all of Friday's deals higher
|
| 12/11/2003 | CV | Fitch rates Wyeth converts A-
|
| 12/11/2003 | CV | Market Commentary: CenterPoint bid 0.125 over par in gray market; Wyeth rises to 101.875; Citizens soars on sale possibility
|
| 12/11/2003 | CV | Wyeth sells $850 million convertible floater at 6-mo Libor minus 50 bps, up 57.5%
|
| 12/10/2003 | CV | S&P rates new Wyeth convertibles A
|
| 12/10/2003 | CV | Market Commentary: Magnum, Scottish Re, CenterPoint emerge; Emulex, Akamai decline; Wyeth bid 0.5 over par in gray
|
| 12/9/2003 | CV | Wyeth $850 million convertible floater talked at Libor minus 25-75 bps, up 55-60%
|
| 12/9/2003 | CV | Market Commentary: Another $2.575 billion of deals; Akamai, Emulex both reoffered at 98
|
| 7/15/2003 | CV | New Issue: Goldman Sachs prices $64.41 million 7% notes exchangeable for Wyeth
|
| 7/26/2002 | CV | New Issue: Goldman Sachs prices $25 million 11.5% notes mandatorily exchangeable for Wyeth
|
